Unveiling the science behind erectile dysfunction topical therapy: investigating transdermal papaverine as a novel treatment approach
Sexual Medicine Reviews · 25.09.2024 · 12 (4) · 720-730
DOI: 10.1093/sxmrev/qeae059 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Sexual Medicine Reviews, online erschienen am 23.08.2024. Verfasst von Hojjat Rezaiezadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Papaverine, Erectile Dysfunction, Administration, Cutaneous. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Introduction
Erectile dysfunction is among the most prevalent urologic issues affecting men globally and is characterized by a high incidence rate. This condition significantly affects the quality of life of patients and their sexual partners.
Objectives
Due to the interactions, contraindications, and side effects associated with systemic drugs, recent research has increasingly focused on topical and transdermal medications for the treatment of erectile dysfunction.
Methods
Based on previous studies, this article examines papaverine in terms of local effectiveness, methods of increasing therapeutic efficiency, possible local side effects, and evaluation of its various formulations.
Results
Among these approaches, notable strategies include using novel formulations and nanoformulations as compared with classic ones, employing permeation enhancers, and combining treatments with other oral and topical drugs with synergistic mechanisms. These methods aim to improve transdermal papaverine’s bioavailability and therapeutic efficacy while minimizing side effects and enhancing patient compliance.
Conclusion
Transdermal papaverine may not be as effective as its injectable form, but the treatment path is more pleasant, with less pain and fewer side effects for patients. For this reason, using solutions that remove the penile skin and fascial absorption barrier can be very effective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.
- School of Nursing and Midwifery, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Toxicology and Pharmacology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.
Zitieren
APA
Rezaiezadeh, H., Ranjbar Tavakoli, M., Langarizadeh, M. A., Saeedi Garaghani, Z., & Karami-Mohajeri, S. (2024). Unveiling the science behind erectile dysfunction topical therapy: investigating transdermal papaverine as a novel treatment approach. Sexual Medicine Reviews, 12(4), 720-730. https://doi.org/10.1093/sxmrev/qeae059
Vancouver
Rezaiezadeh H, Ranjbar Tavakoli M, Langarizadeh MA, Saeedi Garaghani Z, Karami-Mohajeri S. Unveiling the science behind erectile dysfunction topical therapy: investigating transdermal papaverine as a novel treatment approach. Sexual Medicine Reviews. 2024;12(4):720-730. doi:10.1093/sxmrev/qeae059
BibTeX
@article{Rezaiezadeh2024,
author = {Rezaiezadeh, Hojjat and Ranjbar Tavakoli, Marziyeh and Langarizadeh, Mohammad Amin and Saeedi Garaghani, Zahra and Karami-Mohajeri, Somayyeh},
title = {Unveiling the science behind erectile dysfunction topical therapy: investigating transdermal papaverine as a novel treatment approach},
journal = {Sexual Medicine Reviews},
year = {2024},
volume = {12},
number = {4},
pages = {720--730},
doi = {10.1093/sxmrev/qeae059}
}
EUVIMED